Fig. 1From: The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD – the exploratory randomized controlled double-blind ExplorIRON-CKD studyConsort diagram 168 patients were referred to the kidney anemia services and pre-screened; 99 of those fulfilled in principle the eligibility criteria and were contacted. 35 patients accepted to be screened, and 27 were eligible for the trial. One participant withdrew from the trial prior to randomizationBack to article page